News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
214 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (4345)
February (4356)
March (4476)
April (4722)
May (4999)
June (4103)
July (3643)
August (3330)
September (4039)
October (5056)
November (4470)
December (3799)
Day
1 (15)
2 (202)
3 (277)
4 (157)
5 (4)
6 (20)
7 (338)
8 (259)
9 (169)
10 (136)
11 (69)
12 (2)
13 (5)
14 (180)
15 (278)
16 (196)
17 (214)
18 (92)
19 (3)
20 (8)
21 (80)
22 (246)
23 (224)
24 (214)
25 (91)
26 (1)
27 (5)
28 (191)
29 (236)
30 (198)
31 (235)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Drug Development
AgeneBio Announces First Patient Enrollment in the Phase 3 Clinical Trial to Evaluate AGB101 to Treat Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease
- AGB101 is the first investigational therapeutic that targets the reduction of hippocampal overactivity. - The study evaluates both Primary and Secondary Endpoints to measure cognitive and functional efficacy. - Secondary imaging endpoints will include measures of neurodegeneration.
January 17, 2019
·
4 min read
Pharm Country
Children with Autism See Improvement after Treatment with Tikun Olam High-CBD, Low-THC Medical Cannabis, New Study Shows
Children with Autism Spectrum Disorder (ASD) see a “significant” improvement in symptoms and less reliance on other medications after treatment with Tikun Olam’s Avidekel™ medical cannabis, as confirmed by a new study published in the Scientific Journal Review.
January 17, 2019
·
2 min read
Liht Cannabis Corp. Secures Exclusive Canadian Rights to Proprietary Technologies for the Quality Cultivation and Tracking of Cannabis
Liht Cannabis Corp. (CSE: LIHT) (OTCQX: LIHTF) or the “Company”) is pleased to announce that its wholly-owned subsidiary, Full Spectrum Medicinals (“FSM”), has completed the securing of the exclusive rights to the S5 Agro Technology Suite (the “S5-ATS”) proprietary technology. T
January 17, 2019
·
9 min read
BioCapital
Red Cross Reaches 500 Lives Saved from Home Fires; Volunteers to Install Free Smoke Alarms on MLK Day of Service
As the nation prepares for MLK Day of Service on Monday, the American Red Cross announced today that volunteers have helped save the lives of more than 500 people through its Home Fire Campaign.
January 17, 2019
·
3 min read
Biotech Bay
First Cancer Patients in Taiwan Treated with Varian HyperArc High-Definition Radiotherapy
Varian (NYSE: VAR) announced 10 patients at the Chi Mei Medical Center with brain lesions became the first patients in Taiwan to be treated using the company’s HyperArc™ High Definition Radiotherapy (HDRT), a new type of radiosurgery treatment solution.
January 17, 2019
·
2 min read
Biotech Beach
PSC Software™ Launches Functionality Innovation by Adding API to Flagship Product, Adaptive Compliance Engine™
PSC Software™ announced today that their flagship product, Adaptive Compliance Engine™ (ACE), a software-as-a-service (SaaS) enterprise quality management system and document management solution, now offers application programming interface (API) capabilities as of ACE version 3.3.3.
January 17, 2019
·
2 min read
Diaceutics Opens Asian Hub to Capitalize on Growing Market
Diaceutics, today announces that it is opening a new regional hub in Asia.
January 17, 2019
·
4 min read
FDA
Omeros Finalizes with FDA Clinical Plan for OMS721 Approval in IgA Nephropathy
Additional Positive Data Reported from Second Cohort in Phase 2 Trial
January 17, 2019
·
10 min read
Business
Geneia Applauds HHS Strategy to Reduce Administrative Burden of EHRs and Health IT
There’s a role for all in healthcare to improve the Physician Misery Index
January 17, 2019
·
2 min read
Pharm Country
Novel Oral Antibiotic Treatment Seysara™ (sarecycline) Now Available
Almirall LLC announces the launch of Seysara
January 17, 2019
·
8 min read
Previous
6 of 22
Next